200 related articles for article (PubMed ID: 34004052)
1. Rhabdomyosarcoma with epithelioid morphology: A challenging cytologic diagnosis in a pleural effusion.
Rodgers S; Datta L; Perry KD; Stone CH
Diagn Cytopathol; 2021 Sep; 49(9):E356-E359. PubMed ID: 34004052
[TBL] [Abstract][Full Text] [Related]
2. Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma.
Jo VY; Mariño-Enríquez A; Fletcher CD
Am J Surg Pathol; 2011 Oct; 35(10):1523-30. PubMed ID: 21921782
[TBL] [Abstract][Full Text] [Related]
3. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
4. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
5. Effusion cytology of epithelioid rhabdomyosarcoma.
Renshaw AA; Gould EW
Diagn Cytopathol; 2019 Oct; 47(10):1042-1044. PubMed ID: 31017725
[TBL] [Abstract][Full Text] [Related]
6. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
Rekhi B; Dodd L; Dharavath B; Dutt A
Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic evaluation of metastatic rhabdomyosarcoma in effusion specimens.
Alderman MA; Thomas DG; Roh MH
Diagn Cytopathol; 2013 Nov; 41(11):955-9. PubMed ID: 23584957
[TBL] [Abstract][Full Text] [Related]
8. Epithelioid rhabdomyosarcoma: Report of the first case in the jaw.
de Aguiar MCF; de Noronha MS; Silveira RL; Araújo JAD; Werkema FS; Bell D; Caldeira PC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):e308-e315. PubMed ID: 32173396
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanotic nerve sheath tumor in pleural effusion: Deceitful cytology with significant repercussions.
Jackson C; Linos K; Liu X
Diagn Cytopathol; 2022 Mar; 50(3):E76-E80. PubMed ID: 34698454
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study.
Zin A; Bertorelle R; Dall'Igna P; Manzitti C; Gambini C; Bisogno G; Rosolen A; Alaggio R
Am J Surg Pathol; 2014 Feb; 38(2):273-8. PubMed ID: 24418861
[TBL] [Abstract][Full Text] [Related]
12. Epithelioid Rhabdomyosarcoma; a case report with immunohistochemical and molecular study.
Jokoji R; Ikeda J; Tsujimoto M; Morii E
Diagn Pathol; 2015 Jul; 10():124. PubMed ID: 26208724
[TBL] [Abstract][Full Text] [Related]
13. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
Rekhi B; Upadhyay P; Ramteke MP; Dutt A
Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.
Morotti RA; Nicol KK; Parham DM; Teot LA; Moore J; Hayes J; Meyer W; Qualman SJ;
Am J Surg Pathol; 2006 Aug; 30(8):962-8. PubMed ID: 16861966
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma.
Dehner CA; Geiersbach K; Rowsey R; Murugan P; Broski SM; Meis JM; Rosenberg AE; Folpe AL
Mod Pathol; 2023 Jun; 36(6):100131. PubMed ID: 36966552
[TBL] [Abstract][Full Text] [Related]
16. [Rhabdomyosarcomas: structural distribution and analysis of an immunohistochemical profile].
Botiralieva GK; Sharlai AS; Roshchin VY; Sidorov IV; Konovalov DM
Arkh Patol; 2020; 82(5):33-41. PubMed ID: 33054030
[TBL] [Abstract][Full Text] [Related]
17. Soft Tissue Special Issue: Skeletal Muscle Tumors: A Clinicopathological Review.
Kohashi K; Kinoshita I; Oda Y
Head Neck Pathol; 2020 Mar; 14(1):12-20. PubMed ID: 31950473
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous epithelioid rhabdomyosarcoma: a rare, recently described entity with review of the literature.
Feasel PC; Marburger TB; Billings SD
J Cutan Pathol; 2014 Jul; 41(7):588-91. PubMed ID: 24628673
[TBL] [Abstract][Full Text] [Related]
19. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.
Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Furihata M; Ohtsuki Y
Int J Oncol; 2000 Jul; 17(1):119-25. PubMed ID: 10853028
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of New Monoclonal Anti-MyoD1 (MX049) for the Diagnosis of Rhabdomyosarcoma: Comparison with 5.8A, EP212, Anti-Desmin, Anti-Myogenin, and Fluorescence
He Y; Chen X; Yu X
Ann Clin Lab Sci; 2020 May; 50(3):412-416. PubMed ID: 32581037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
